ASH 2025 Lymphoma Highlights: Epcoritamab, S1826, Mosunetuzumab & ctDNA | Dr. Sworder
oncologytube.com
ASH 2025 Lymphoma Highlights: Epcoritamab, S1826, Mosunetuzumab & ctDNA | Dr. Sworder
ASH 2025 lymphoma highlights featuring Dr. Brian Sworder: epcoritamab R² in relapsed follicular lymphoma, S1826 3-year update in Hodgkin lymphoma, mosunetuzumab for elderly DLBCL, and ctDNA monitoring for relapse prediction. Expert interview & key data.
3 months ago
Related Products
Epcoritamab Books
Epcoritamab Mechanism of Action
Epcoritamab Mugs
#Epcoritamab Clinical Trials
Genmab A/S: Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Genmab A/S: Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
finanznachrichten.de5 months ago
Clinical Trials | Alzheimers.gov
Clinical Trials | Alzheimers.gov
alzheimers.govAug 30, 2023
Top videos
EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab With Rituximab and Lenalidomide (R2) vs R2 Alone in Patients With Relapsed or Refractory Follicular Lymphoma | OncLive
11:07
EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab With Rituximab and Lenalidomide (R2) vs R2 Alone in Patients With Relapsed or Refractory Follicular Lymphoma | OncLive
onclive.com
Jan 23, 2024
Hear Grzegorz S. Nowakowski, MD, of Mayo Clinic discuss the clinical implications of the FDA approval of third-line epcoritamab for relapsed/refractory #follicularlymphoma. https://www.onclive.com/view/dr-nowakowski-on-the-implications-of-the-fda-approval-of-epcoritamab-in-follicular-lymphoma | OncLive
1:35
Hear Grzegorz S. Nowakowski, MD, of Mayo Clinic discuss the clinical implications of the FDA approval of third-line epcoritamab for relapsed/refractory #follicularlymphoma. https://www.onclive.com/view/dr-nowakowski-on-the-implications-of-the-fda-approval-of-epcoritamab-in-follicular-lymphoma | OncLive
FacebookOncLive
138 viewsOct 28, 2024
Epcoritamab Combination Sets New Standard in Second-Line Follicular Lymphoma Care | Pharmacy Times
Epcoritamab Combination Sets New Standard in Second-Line Follicular Lymphoma Care | Pharmacy Times
pharmacytimes.com
4 months ago
Epcoritamab Side Effects
Raw Cacao Side Effects and Benefits | LoveToKnow Health & Wellness
Raw Cacao Side Effects and Benefits | LoveToKnow Health & Wellness
lovetoknowhealth.com
Apr 21, 2022
What Are the Side Effects of the Lepto Vaccine in Dogs?
What Are the Side Effects of the Lepto Vaccine in Dogs?
pethelpful.com
May 27, 2022
Do Not Overdose Almonds As It Can Have These 8 Side Effects
Do Not Overdose Almonds As It Can Have These 8 Side Effects
onlymyhealth.com
Mar 31, 2021
EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab With Rituximab and Lenalidomide (R2) vs R2 Alone in Patients With Relapsed or Refractory Follicular Lymphoma | OncLive
11:07
EPCORE FL-1: Phase 3 Trial of Subcutaneous Epcoritamab With …
Jan 23, 2024
onclive.com
Hear Grzegorz S. Nowakowski, MD, of Mayo Clinic discuss the clinical implications of the FDA approval of third-line epcoritamab for relapsed/refractory #follicularlymphoma. https://www.onclive.com/view/dr-nowakowski-on-the-implications-of-the-fda-approval-of-epcoritamab-in-follicular-lymphoma | OncLive
1:35
Hear Grzegorz S. Nowakowski, MD, of Mayo Clinic discuss the clinica…
138 viewsOct 28, 2024
FacebookOncLive
Epcoritamab Combination Sets New Standard in Second-Line Follicular Lymphoma Care | Pharmacy Times
Epcoritamab Combination Sets New Standard in Second-Line Follicula…
4 months ago
pharmacytimes.com
Genmab A/S: Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
Genmab A/S: Genmab Announces Data From Multiple Clinical Trials …
5 months ago
finanznachrichten.de
Dr Nowakowski on Monitoring Epcoritamab-Associated ICANS and CRS in Follicular Lymphoma | OncLive
Dr Nowakowski on Monitoring Epcoritamab-Associated ICANS a…
Sep 10, 2024
onclive.com
Dr Patel on Choosing Between Mosunetuzumab and Epcoritamab in Follicular Lymphoma | OncLive
Dr Patel on Choosing Between Mosunetuzumab and Epcoritama…
May 2, 2025
onclive.com
R/R FL: FDA Approval of Epcoritamab-bysp R² - Efficacy Data, Clinical Practice Considerations for Mitigating Infection Risk and Administration in the Outpatient Setting
R/R FL: FDA Approval of Epcoritamab-bysp R² - Efficacy Da…
5 months ago
vumedi.com
1:53
Epkinly (epcoritamab-bysp)- refractory diffuse large B-cell lym…
470 viewsJul 27, 2024
YouTubePharmacy Talk USA
How the FDA Approval of Epcoritamab R² Shifts the Landsc…
5 months ago
vumedi.com
1:36
ASH 2025 | EPCORE FL-1 phase III primary results: Epcoritamab + R…
327 views5 months ago
YouTubeLymphoma Hub
5:53
ASH 2025 | EPCORE FL-1 phase III primary results: Epcoritamab + R…
2 views5 months ago
YouTubeLymphoma Hub
Overview of the Fixed-Duration Epcoritamab R-Mini-CHOP in Patie…
May 8, 2025
onclive.com
0:59
Dr Leslie on Epcoritamab Plus Lenalidomide and Rituximab in Fo…
105 views5 months ago
YouTubeOncLive
2:30
Dr Nowakowski on the EPCORE NHL-1 Trial Results of Epcoritama…
155 viewsSep 4, 2024
YouTubeOncLive
5:31
Advances in Lymphoma From ASH 2025: EPCORE FL-1, Epcoritamab …
1K views4 months ago
YouTubeOncUpdates: Latest Oncology Insights
1:52
EHA 2025 | How effective is epcoritamab + R-ICE in patients wi…
364 views11 months ago
YouTubeLymphoma Hub
0:36
Epcoritamab + R-CHOP overcomes high total metabolic tumor volum…
138 viewsDec 9, 2024
YouTubeVJHemOnc – Video Journal of Hematology & H…
9:54
FDA Accepts for Priority Review BLA for Epcoritamab in Relapsed/…
256 viewsMar 21, 2023
YouTubeHPR
Genmab's Phase 3 Study with Epcoritamab Fails to Meet Overall …
4 months ago
marketscreener.com
1:25
Guidance on the use of epcoritamab for the treatment of follicular lymp…
104 views11 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:22
Treatment Options of B-Cell Lymphoma: Glofitamab vs. Epcori…
843 viewsJul 31, 2024
YouTubeGlobal Resource for Advancing Cancer Education
Targeted Therapies and Bispecific Antibodies in Second-Line Follicul…
4 months ago
ajmc.com
Genmab Announces Phase 3 EPCORE FL-1 Clinical Trial Met Du…
5 months ago
finanznachrichten.de
8:00
Genmab and AbbVie Present New Epcoritamab Data at EHA 2023
280 viewsSep 7, 2023
YouTubeHPR
10:07
Epcoritamab plus rituximab and lenalidomide improves efficacy in …
3 weeks ago
YouTubeecancer
16:59
Optimal Use of Epcoritamab in Follicular Lymphoma
211 viewsMar 4, 2025
YouTubeBlood Cancers Today
Genmab A/S: Genmab Announces New Data from Phase 1b/2 EPCOR…
9 months ago
finanznachrichten.de
3:02
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cel…
551 viewsMay 3, 2024
YouTubeGlobal Resource for Advancing Cancer Education
1:28
MAIC of epcoritamab with R-squared versus tafasitamab with …
92 views11 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder